Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.421 USD | 0.00% | +0.26% | -43.12% |
Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
Mar. 26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.58M |
---|---|---|---|---|---|
Net income 2023 * | -12M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on NeuBase Therapeutics, Inc.
1 week | +0.26% | ||
Current month | -6.42% | ||
1 month | -59.13% | ||
3 months | -30.07% | ||
6 months | -38.08% | ||
Current year | -43.12% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Eric Richman
BRD | Director/Board Member | 63 | 19-07-11 |
Director/Board Member | 79 | 19-07-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.421 | 0.00% | 21,218 |
24-04-23 | 0.421 | +0.24% | 58,425 |
24-04-22 | 0.42 | -2.33% | 157,792 |
24-04-19 | 0.43 | -0.83% | 88,885 |
24-04-18 | 0.4336 | +3.26% | 47,877 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-43.12% | 1.58M | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- NBSE Stock